Capital Analysts, LLC
Position in ACHV — Achieve Life Sciences, Inc.
CIK 1624758
FORT WASHINGTON, PA
Position in ACHV
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,058
-$1,421 QoQ
Shares Held
700
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 81 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital Analysts, LLC holds $1,026,985 across 15 Biotechnology names. ACHV ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
9,179 | $466,292 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
520 | $401,772 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
119 | $53,137 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
2,788 | $26,262 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
446 | $25,194 | |
| 6 | OMER |
Omeros Corp
|
1,000 | $10,560 | |
| 7 | SPRY |
ARS Pharmaceuticals, Inc.
|
1,300 | $10,439 | |
| 8 | VRCA |
Verrica Pharmaceuticals Inc.
|
1,500 | $7,935 |
All Filings in ACHV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,058 | 700 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,479 | 700 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,606 | 510 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||